Anna Nilson

Head of Clinical Operations, Desentum

Anna has 25 years of experience in clinical operations. She has worked for both small and large companies as well as a contract research organization (CRO). In the beginning of her career, she coordinated international clinical studies at pharmaceutical companies such as Leiras and Zeneca, and managed clinical trial activities for a CRO company Medfiles. She has also managed and coordinated clinical development projects for novel drugs and medical devices at Hormos Medical and Novagenesis. Later on, Anna has worked for large pharmaceutical companies Pfizer and Bristol-Myers Squibb in the role of Scientific Advisor, maintaining relationships to key opinion leaders and organizing activities requiring scientific input. Before joining Desentum in 2018, Anna led a global clinical team at PerkinElmer for six years, being responsible for clinical study strategies of in vitro medical device products to support market access. At Desentum, Anna is responsible for clinical operations and relations with external clinical partners.

Anna holds an MSc degree in biology in the University of Turku.